Unlocking the keys to mild COVID-19 cases in infants

According to investigators, infants may have an edge over adults, with babies demonstrating a stronger immune response to the SARS-CoV-2 virus.

Nevakar announces formation of ophthalmic subsidiary, Vyluma

Vyluma Inc. will focus on the development and commercialization of therapies to treat ophthalmic diseases, including pediatric myopia.

Physician shines spotlight on mass distribution of azithromycin for trachoma control

Investigators find increased treatment regimen is effective and long-lasting for patients.